leonurine has been researched along with Diabetes Mellitus, Type 2 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, H; Liu, X; Wen, D; Xin, H; Xu, Y; Zhang, Y; Zhu, YZ | 1 |
1 other study(ies) available for leonurine and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Novel anti-diabetic effect of SCM-198 via inhibiting the hepatic NF-κB pathway in db/db mice.
Topics: Adipose Tissue, White; Animals; Anti-Inflammatory Agents; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Gallic Acid; Hypoglycemic Agents; Inflammation Mediators; Leonurus; Liver; Male; Mice; Mice, Inbred C57BL; NF-kappa B | 2012 |